Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine

被引：44

作者：

Koong, Lin Ru ^{[1
]}

Chee, Wai Kitt ^{[1
]}

Toh, Zhi Hong ^{[1
]}

Ng, Xin Le ^{[1
]}

Agrawal, Rupesh ^{[1
,2
,3
,4
]}

Ho, Su Ling ^{[1
]}

机构：

[1] Tan Tock Seng Hosp, Natl Healthcare Grp Eye Inst, Singapore 308433, Singapore

[2] Lee Kong Chian Sch Med, Singapore, Singapore

[3] Singapore Eye Res Inst, Ocular Infect & AntiMicrobials, Singapore, Singapore

[4] Duke NUS Med Sch, Acad & Clin Programme, Ophthalmol & Visual Sci, Singapore, Singapore

来源：

OCULAR IMMUNOLOGY AND INFLAMMATION | 2021年 / 29卷 / 06期

关键词：

COVID-19; vaccine; VKH disease; PfizerBioNtech; vaccine side effects; exudative retinal detachment;

D O I：

10.1080/09273948.2021.1974492

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.

引用

页码：1212 / 1215

页数：4

共 11 条

[1] Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis [J].

Aggarwal, Kanika ;

Agarwal, Aniruddha ;

Jaiswal, Nishant ;

Dahiya, Neha ;

Ahuja, Alka ;

Mahajan, Sarakshi ;

Tong, Louis ;

Duggal, Mona ;

Singh, Meenu ;

Agrawal, Rupesh ;

Gupta, Vishali .

PLOS ONE, 2020, 15 (11)

[2] SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond [J].

Bettini, Emily ;

Locci, Michela .

VACCINES, 2021, 9 (02) :1-20

[3] Acute macular neuroretinopathy following COVID-19 vaccination [J].

Bohler, Anders Djupesland ;

Strom, Marianne Ekornes ;

Sandvig, Kjell Ulrik ;

Moe, Morten Carstens ;

Jorstad, Oystein Kalsnes .

EYE, 2022, 36 (03) :644-645

[4] Vogt-Koyanagi-Harada-like Disease following Yellow Fever Vaccination [J].

Campos, Wesley R. ;

Cenachi, Sarah P. F. ;

Soares, Matheus Schmidt ;

Goncalves, Priscila Freitas ;

Vasconcelos-Santos, Daniel V. .

OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (01) :124-127

[5] COVID-19 Vaccine Frontrunners and Their Nanotechnology Design [J].

Chung, Young Hun ;

Beiss, Veronique ;

Fiering, Steven N. ;

Steinmetz, Nicole F. .

ACS NANO, 2020, 14 (10) :12522-12537

[6] Vaccine-Associated Uveitis [J].

Cunningham, Emmett T., Jr. ;

Moorthy, Ramana S. ;

Fraunfelder, Frederick W. ;

Zierhut, Manfred .

OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (04) :517-520

[7] Classification Criteria for Vogt-Koyanagi-Harada Disease [J].

Jabs, Douglas A. ;

Denniston, Alastair K. ;

Dick, Andrew D. ;

Dunn, James P. ;

Kramer, Michal ;

McCluskey, Peter ;

Oden, Neal ;

Okada, Annabelle A. ;

Palestine, Alan G. ;

Read, Russell W. ;

Thorne, Jennifer E. ;

Trusko, Brett E. .

AMERICAN JOURNAL OF OPHTHALMOLOGY, 2021, 228 :205-211

[8] Vogt-Koyanagi-Harada Syndrome following influenza vaccination [J].

Kim, Moosang .

INDIAN JOURNAL OF OPHTHALMOLOGY, 2016, 64 (01) :98-98

[9] Panuveitis following Vaccination for COVID-19 [J].

Mudie, Lucy I. ;

Zick, Jon D. ;

Dacey, Mark S. ;

Palestine, Alan G. .

OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (04) :741-742

[10] Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, following anti-SARS-CoV-2 vaccination [J].

Papasavvas, Ioannis ;

Herbort, Carl P., Jr. .

JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2021, 11 (01)

← 1 2 →